Texas lawyer for Vimovo kidney failure and other side effects.The anti-arthritis and antacid drug Vimovo has been linked to serious side effects, including stomach cancer, kidney inflammation (nephritis), renal disease, and kidney failure.

Need a Texas Vimovo Lawyer? Collen A. Clark is a true advocate for his clients and is passionate about helping Texans that have been injured or wronged. If you or a loved one was diagnosed with severe side effects, you should contact our lawyers immediately. You may be entitled to compensation by filing a lawsuit.

Vimovo and Stomach Cancer

In November 2017, a study published in the journal Gut found a doubled (2X) higher risk of stomach cancer for people who were on long-term treatment with heartburn medications in the Proton Pump Inhibitor (PPI) class, which includes popular antacids like Vimovo.

Vimovo Lawsuits Centralized in MDL

August 2017 — Judges have centralized 161 lawsuits involving kidney injuries from Vimovo and other PPI heartburn drugs into Multi-District Litigation (MDL No. 2798) under Judge Claire C. Cecchi in the District of New Jersey — In RE: Proton-Pump Inhibitor Products Liability Litigation (No. II). Drug-makers are accused of failing to warn that Vimovo can cause kidney injuries, Chronic Kidney Disease (CKD), acute interstitial nephritis, end-stage kidney disease, or kidney failure.

Study Links Heartburn Drugs and Death

July 2017 — A new study published in BMJ Open has found up to a 50% increased risk of death for people who use PPI heartburn drugs for 1-2 years instead of another type of heartburn drugs called H2-blockers. long-term use of PPI heartburn drug. Click here to read more.

Heartburn Drugs Causing Massive Health Problems

Vimovo Linked to 96% Higher Risk of Kidney Failure

April 2016 — A study published in the Journal of the American Society of Nephrology has linked the use of anti-heartburn medications in the PPI class to a 96% increased risk of kidney failure and a 26% increased risk of chronic kidney disease. Click here to read more.

Overview

Vimovo is a medication created by AstraZeneca that was approved by the FDA in 2010. It contains a combination of two medications:

  • Naproxen: A Non-Steroidal Anti-Inflammatory Drug (NSAID) that is used to reduce pain, inflammation, and swelling
  • Esomeprazole: A Proton-Pump Inhibitor (PPI), which reduces the amount of acid that it produced by the stomach

Most people take Vimovo to treat rheumatoid arthritis, osteoarthritis, or a type of spinal arthritis called ankylosing spondylitis. One problem with long-term use of an NSAID is the risk of stomach ulcers. Vimovo contains a PPI to reduce the risk of these ulcers.

Vimovo and Bone Fractures

One ingredient in Vimovo, esomeprazole, is a PPI. Unfortunately, long-term use of PPIs has been linked to some serious side effects. A study published in the British Medical Journal in January 2012 found that women who used a PPI for at least two years were 35% more likely to have a bone fracture.

Several other studies have also found that long-term use of a PPI increases the risk of a bone fracture. The FDA first warned about this possible risk in May 2010. Recently, the FDA warned that using PPIs for more than one year increases the risk of bone fractures.

Vimovo and Low Magnesium

In March 2011, the FDA warned about the risk of dangerously low magnesium levels (a condition called hypomagnesemia) associated with the use of Proton Pump Inhibitors (PPIs), such as Vimovo, for at least one year.

People who suffer from hypomagnesemia may have severe muscle spasms, irregular heartbeat, arrhythmia, or convulsions.

The FDA has published guidelines for doctors who are prescribing Vimovo or other PPIs to patients who will probably take the drug for more than one year. New patients should have a blood test to check for normal blood-magnesium levels. Furthermore, doctors should be aware that the risk of hypomagnesemia may be higher for patients who also take diuretics, digoxin, or other medications that are known to lower magnesium levels.

Kidney Inflammation Linked to Vimovo

In December 2014, the FDA updated the label on Vimovo and other PPIs to include acute interstitial nephritis. This side effect involves sudden inflammation and swelling in the spaces between tubules inside the kidneys. It is usually caused by an allergic reaction to medications in the bloodstream. Without proper diagnosis and treatment, it can lead to permanent kidney damage or even renal failure.

Kidney Side Effects of Vimovo

  • Interstitial nephritis
  • Kidney inflammation
  • Acute kidney injury
  • Chronic kidney disease

Vimovo Side Effects

  • Stomach cancer
  • Bone fractures (hip, wrist, and spine)
  • Hypomagnesemia (dangerously low magnesium levels)
  • Heart attack
  • Stroke
  • Allergic reaction, which may be deadly
  • Inflammation or irritation of the stomach lining, stomach ulcers, indigestion

Need a Vimovo Lawyer in Texas?

Collen A. Clark is a true advocate for his clients and is passionate about helping Texans that have been injured or wronged.

Collen’s amazing success in the courtroom and well known dedication to his clients has earned him the recognition of his peers as one of The Top Trial Lawyers in Texas.”

The Clark Firm has assembled a team of trial lawyers with more than 100 years experience, participation in over 600 jury trials and $260 million in verdicts and/or settlements. Please use the form below to contact our Texas Vimovo lawyers for a free lawsuit review.